Study highlights potential of p-tau217 assays in Alzheimer’s clinical trials and diagnosis Post author: Post published:March 14, 2024 Post category:uncategorized The performance of two commercial phospho-tau217 (p-tau217) assays. You Might Also Like Huntsman Cancer Institute joins innovative clinical trials program for blood cancers December 17, 2024 UIC studies reveal Rise in lidocaine poisonings despite overall drop in anesthetic deaths October 6, 2025 Can People with Type 1 Diabetes Also Get Type 2? April 9, 2024
Huntsman Cancer Institute joins innovative clinical trials program for blood cancers December 17, 2024
UIC studies reveal Rise in lidocaine poisonings despite overall drop in anesthetic deaths October 6, 2025